Why we invested in Jutro Medical
Their model for the future of healthcare is just what the doctor ordered.
What do you call it when a business idea not only solves a mission-critical problem, but fundamentally changes the way a familiar experience works in a way that customers love? We’re asking because we need this word to use it to help explain why we’re so excited about investing in Jutro Medical.
They’ve made their name by leveraging the role of technology to establish themselves as a truly mobile-first primary care provider with an irresistible customer experience and a goal to shift healthcare from reactive to being truly preventive and proactive. In an age when everyone is seeking convenience through their smart mobile devices, Jutro Medical is a convenient, efficient and — yes, really — enjoyable way to make primary care arrangements.
Use Jutro Medical for a day and you’ll agree — the days of traditional clinics are numbered!
An apple a day keeps the doctor… ready when you are?
Here’s how Jutro Medical delights patients. They make doctors available to answer simple questions via chat within minutes of a request. If it turns out that an in-person visit to a clinic is needed, users can schedule the appointment for the next available time slot and then simply show up at the appointed time and go straight to a doctor who already has the necessary documentation and can devote all of his or her time to patient care.
Less filling out forms, more talking about the care you need. Fewer administrative tasks, more doing the things doctors are meant to.
Using technology to process repetitive tasks associated with the bureaucratic side of healthcare is a cornerstone of Jutro Medical’s value. And it’s more than the ease and convenience of quickly getting access to medical professionals — there are strong benefits for both sides.
Remember that mission-critical problem we mentioned earlier? It’s a significant challenge that confronts the healthcare industry going forward — the huge expected shortage of GPs in the not-so-distant future. Having backed Infermedica in April 2019, which helps direct patients to the right care, we are happy to support another company that is targeting this issue.
Jutro Medical is also using technology to help bridge that gap. How? By doubling the efficiency of doctors and letting them focus on work that actually matters, like diagnosis and treatment, rather than admin tasks and paperwork. That’s literally what automation is for.
This freedom to focus on real patient care is not only a plus for patients, it allows doctors and other medical professionals to do the work they’re trained to do instead of the time-wasting paperwork they’re usually forced to do. This means greater work satisfaction and higher productivity than in other facilities.
Jutro Medical achieves higher margins than other players and — here comes the best part — this kind of service doesn’t cost a fortune, it is actually available for free for the patients (one just has to sign up to Jutro through the National Health Fund — NFZ).
Happier patients and happier doctors — the perfect prescription for business health!
Small beginnings, huge potential
Inovo’s investment relationship with Jutro Medical started small in November 2020 but after working with Adam Janczewski on a weekly basis, we regard him as one of the top founders in our portfolio and appreciate what he and his team are doing even more. That’s why we decided to double-down, making Jutro our largest investment to date. We led their EUR 6M Seed this year, with co-investors like Rheingau Founders, MOC, and a group of prominent business angels.
The Jutro Medical team impressed us right from the start of our early cooperation. We watched as they beat just about every target they set and repeatedly showed that they are ready to make bold decisions when needed.
In fact, we continue to be so impressed that everyone at Inovo switched their medical provider to Jutro last year, and we are even more in love with their product. We’re convinced that their UX is miles ahead of any public or private alternative.
Right now, Jutro is only active in Poland but this is a market that is “only” worth well north of EUR 2.4B (addressable Jutro market out of EUR 32B health expenditure in Poland), meaning there’s room for a unicorn in this industry in one national market.
But borders don’t mean much to ambitious founders and Adam Janczewski already has his sights set on bigger goals.
An international rollout is definitely possible and we’re confident that once Jutro decides on it, they can challenge both Babylon Health and KRY in some key markets.
It’s been amazing to watch the amount of interest in Jutro Medical skyrocket and we can’t wait to follow their journey as they pioneer the use of virtual and digital twists in this most traditional of fields.
Inovo Venture Partners is a first-choice VC for ambitious founders from Poland and the CEE region. We back early-stage, post-traction startups with up to €3M of initial investment, and help them build global brands while driving growth of the local startup ecosystem. We take great pride in being close to top founders who think big. We’re investors in: Booksy, Restaumatic, Sotrender, Infermedica, Spacelift, Tidio, AI Clearing, Zowie, Jutro Medical, Intiaro, Packhelp, Preply, Eyerim, Allset, SunRoof and Archbee. Our second fund reached a total of €54M.
For more information visit: inovo.vc
